What is Charles River Laboratories's unbilled revenue?

Charles River Laboratories (CRL) reported unbilled revenue of $195.62M in Q1 2026.

How has Charles River Laboratories's unbilled revenue changed year-over-year?

Charles River Laboratories's unbilled revenue decreased by 9.4% year-over-year, from $215.95M to $195.62M.

What is the long-term trend for Charles River Laboratories's unbilled revenue?

Over 5 years (2020 to 2025), Charles River Laboratories's unbilled revenue has grown at a 8.2% compound annual growth rate (CAGR), from $135.4M to $200.59M.

Charles River Laboratories CRL Unbilled Revenue

Unbilled Revenue at other companies

Labcorp HoldingsLH

$161.9M+7.0%

RevvityRVTY

——

Medpace Holdings, Inc.MEDP

——

Other financials

Income statement

See full

Revenue$995.8M+1.2%

Gross profit$349.0M-3.5%

Operating income$119.9M+60.6%

Net income-$14.8M-158%

EPS (diluted)-$0.30-160%

Balance sheet

See full

Cash & equivalents$198.2M-14.5%

Total debt$3.1B+1.9%

Total equity$2.9B-7.9%

Total assets$7.7B+2.0%

Cash flow

See full

Operating cash flow$41.1M-76.1%

CapEx$55.9M-5.8%

Free cash flow-$14.8M-113%

Valuation

See full

Market cap$8.91B+10.3%

Enterprise value$11.79B+8.5%

P/S2.2×+0.2×

Profitability

See full

Gross margin84.7%—

Operating margin13%-2.4pp

Net margin-4.6%—

FCF margin9.7%-4.3pp

Returns & leverage

See full

Return on equity-6%—

Debt / equity1×+0.1×

Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerAssetGrossCurrent.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's unbilled revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Charles River Laboratories's unbilled revenue?: Charles River Laboratories (CRL) reported unbilled revenue of $195.62M in Q1 2026.
How has Charles River Laboratories's unbilled revenue changed year-over-year?: Charles River Laboratories's unbilled revenue decreased by 9.4% year-over-year, from $215.95M to $195.62M.
What is the long-term trend for Charles River Laboratories's unbilled revenue?: Over 5 years (2020 to 2025), Charles River Laboratories's unbilled revenue has grown at a 8.2% compound annual growth rate (CAGR), from $135.4M to $200.59M.